EcoDrugPlus

Neuropeptide Y Receptor Y4

Ensembl ID : ENSOSIG00000010540
Gene Symbol: NPY4R
1 Cross references
135 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSOSIG00000009087
Gene Symbol: NTSR1
1 Cross references
202 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSOSIG00000018960
Gene Symbol: NTRK2
1 Cross references
208 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSOSIG00000022542
Gene Symbol: NTRK3
1 Cross references
192 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSOSIG00000001121
Gene Symbol: NTRK3
1 Cross references
202 Possible Orthologues:

Neurotrophic Tyrosine Kinase, Receptor, Type 2b

Ensembl ID : ENSOSIG00000013970
Gene Symbol: NTRK2B
1 Cross references
200 Possible Orthologues:

Neurotrophic Tyrosine Kinase, Receptor, Type 2b

Ensembl ID : ENSOSIG00000013972
Gene Symbol: NTRK2B
1 Cross references
174 Possible Orthologues:

Nfe2 Like Bzip Transcription Factor 2a

Ensembl ID : ENSOSIG00000000556
Gene Symbol: NFE2L2A
1 Cross references
216 Possible Orthologues:

Nicastrin

Ensembl ID : ENSOSIG00000017873
Gene Symbol: NCSTN
1 Cross references
203 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSOSIG00000020923
Gene Symbol: NAMPT
1 Cross references
225 Possible Orthologues:

Notch Receptor 1b

Ensembl ID : ENSOSIG00000010067
Gene Symbol: NOTCH1B
1 Cross references
201 Possible Orthologues:

Notch Receptor 3

Ensembl ID : ENSOSIG00000014381
Gene Symbol: NOTCH3
1 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).